 Deciphera Pharmaceuticals Inc NASDAQ: DCPH will undergo a corporate restructuring to eliminate 35 of its workforce and end a Phase 12 program for solid tumors. Deciphera will implement an organizational restructuring that will result in a workforce reduction of approximately 140 positions. 